Underreporting of conflicts of interest in clinical practice guidelines: Cross sectional study

BMC Medical Ethics

Volumn 14, Issue 1, 2013, Pages

  Bindslev, Julie Bolette Brix ^a,b   Schroll, Jeppe ^a,b   Gøtzsche, Peter C ^a,b   Lundh, Andreas ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Clinical practice guidelines; Conflicts of interest; Disclosure; Transparency

Indexed keywords

ARTICLE; CONFLICT OF INTEREST; CROSS-SECTIONAL STUDY; DENMARK; ECONOMICS; ETHICS; FINANCIAL MANAGEMENT; HUMAN; INCOME; INTERPERSONAL COMMUNICATION; MEDICAL SOCIETY; MEDICINE; PATIENT REFERRAL; PERSONNEL; PRACTICE GUIDELINE; PREVALENCE; SELF REPORT; STANDARD; STATISTICS; TEACHING;

CONFLICT OF INTEREST; CROSS-SECTIONAL STUDIES; DENMARK; DISCLOSURE; FINANCIAL SUPPORT; HUMANS; INCOME; MEDICINE; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; REFERRAL AND CONSULTATION; RESEARCH PERSONNEL; SELF REPORT; SOCIETIES, MEDICAL; TEACHING;

EID: 84876978851     PISSN: None     EISSN: 14726939     Source Type: Journal    
DOI: 10.1186/1472-6939-14-19     Document Type: Article

References (36)

1. On the impossibility of being expert. Fraser AG, Dunstan FD, BMJ 2010 341 6815 10.1136/bmj.c6815 21156739
2. Potential benefits, limitations, and harms of clinical guidelines. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J, BMJ 1999 318 527 530 10.1136/bmj.318.7182.527 10024268
3. Conflict of Interest in Medical Research, Education, and Practice Washington (DC): National Academies Press (US), Lo B, Field MJ, Institute of Medicine (US) Committee on Conflict of Interest in Medical Research, Education, and Practice, 2009
4. Scientific evidence underlying the ACC/AHA clinical practice guidelines. Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC Jr, JAMA 2009 301 831 841 10.1001/jama.2009.205 19244190
5. Conflict of interest in the debate over calcium-channel antagonists. Stelfox HT, Chua G, O'Rourke K, Detsky AS, N Engl J Med 1998 338 101 106 10.1056/NEJM199801083380206 9420342
6. Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review. Wang AT, McCoy CP, Murad MH, Montori VM, BMJ 2010 340 1344 10.1136/bmj.c1344 20299696
7. Cash interests taint drug advice. Taylor R, Giles J, Nature 2005 437 1070 1071 10.1038/4371070a 16237402
8. Conflict of Interest in clinical practice guideline development: a systematic review. Norris SL, Holmer HK, Ogden LA, Burda BU, PLoS One 2011 6 25153 10.1371/journal.pone.0025153 22039406
9. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. Choudhry NK, Stelfox HT, Detsky AS, JAMA 2002 287 612 617 10.1001/jama.287.5.612 11829700
10. Conflict of interest guidelines for clinical guidelines. Williams MJ, Kevat DA, Loff B, Med J Aust 2011 195 442 445 10.5694/mja10.11130 22004385
11. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. Neumann J, Korenstein D, Ross JS, Keyhani S, BMJ 2011 343 5621 10.1136/bmj.d5621 21990257
12. [Physicians' collaboration with the industry-in dry numbers]. Bundgaard B, Ugeskr Laeger 2011 173 464
13. The Danish Medicines Agency, List of permissions granted to physicians and dentists affiliated with pharmaceutical companies [ http://ext. laegemiddelstyrelsen.dk/tilladelselaegertandlaeger/tilladelse-laeger-tandlaeger- full-soeg.asp?vis=hele ] (Accessed 7 January 2013)
14. A sunshine act for Europe. Godlee F, BMJ 2011 343 6593 10.1136/bmj.d6593
15. A unique researcher identifier for the Physician Payments Sunshine Act. Carpenter D, Joffe S, JAMA 2011 305 2007 2008 10.1001/jama.2011.651 21586717
16. Danish Association of Medical Societies, List of Danish Specialty Societies [ http://www.selskaberne.dk/portal/page/portal/LVS/Forside/ Medlemsselskaber/Specialebarende%20og%20ikke-specialebarende#speciale ] (Accessed 7 January 2013)
17. National Board of Health, Danish Authorisation register [ http://www.sst.dk/DS/OpslagAutReg.aspx ] (Accessed 7 January 2013)
18. International Committee of Medical Journal Editors (ICMJE), Form for Disclosure of Potential Conflicts of Interest 2009 [ http://www.icmje.org/coi- disclosure.pdf ] (Accessed 7 January 2013)
19. AGREE II: advancing guideline development, reporting and evaluation in health care. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L, AGREE Next Steps Consortium, CMAJ 2010 182 839 E942 20603348
20. The Danish Medicine Agency, Guidance for physicians and dentists requirement to apply for permission to be affiliated with a pharmaceutical company [ http://laegemiddelstyrelsen.dk/da/service-menu/lovgivning/laegers,- tandlaegers-og-apotekeres-tilkn - virksomhed/laeger-og-tandlaeger/vejledning-om- laegers-og-tandlaegers-pli-virksomhed.aspx ] (Accessed 7 January 2013)
21. Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions. Papanikolaou GN, Baltogianni MS, Contopoulos- Ioannidis DG, Haidich AB, Giannakakis IA, Ioannnidis JPA, BMC Med Res Methodol 2001 1 3 10.1186/1471-2288-1-3 11405896
22. Financial ties between DSM-IV panel members and the pharmaceutical industry. Cosgrove L, Krimsky S, Vijayaraghavan M, Schneider L, Psychother Psychosom 2006 75 154 160 10.1159/000091772 16636630
23. Does the expert panel at the St Gallen meeting provide an unbiased opinion about the management of women with early breast cancer? Hietanen P, Ann Oncol 2009 20 1749 1751 10.1093/annonc/mdp399 19684104
24. Invited Article: conflicts of interest for authors of American Academy of Neurology clinical practice guidelines. Holloway RG, Mooney CJ, Getchius TS, Edlund WS, Miyasaki JO, Neurology 2008 71 57 63 10.1212/01.wnl.0000316319.19159. c3 18591506
25. A national survey of physician-industry relationships. Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D, N Engl J Med 2007 356 1742 1750 10.1056/NEJMsa064508 17460228
26. Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications: an observational study. Norris SL, Holmer HK, Ogden LA, Burda BU, Rongwei F, BMC Med Ethics 2012 13 24 10.1186/1472-6939-13-24 23013260
27. From disclosure to transparency: the use of company payment data. Chimonas S, Frosch Z, Rothman DJ, Arch Intern Med 2011 171 81 86 10.1001/archinternmed.2010.341 20837820
28. Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines. Cosgrove L, Bursztajn HJ, Krimsky S, Anaya M, Walker J, Psychother Psychosom 2009 78 228 232 10.1159/000214444 19401623
29. Physician professionalism and changes in physician-industry relationships from 2004 to 2009. Campbell EG, Rao SR, DesRoches CM, Iezzoni LI, Vogeli C, Bolcic-Jankovic D, Miralles PD, Arch Intern Med 2010 170 1820 1926 Erratum in: Arch Intern Med 2010, 170: 1966 10.1001/archinternmed.2010.383 21059976
30. Physician Financial Transparency Reports (Sunshine Act), American Medical Association [ http://www.ama-assn.org/ama/pub/advocacy/topics/sunshine-act-and- physician-financial-transparency-reports.page ] (Accessed 27 March 2013)
31. [In the future everyone will be able to see what physicians earn from industry]. Rasmussen LI, Ugeskr Laeger 2013 175 618
32. Can We Trust Cardiovascular Practice Guidelines? Nissen SE, Arch Intern Med 2011 171 584 585 10.1001/archinternmed.2011.94 21444850
33. The vexing problem of guidelines and conflict of interest: a potential solution. Guyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, Gutterman D, Lewis SZ, Nathanson I, Jaeschke R, Schünemann H, Ann Intern Med 2010 152 738 741 10.7326/0003-4819-152-11-201006010-00254 20479011
34. The science of reviewing research. Oxman AD, Guyatt GH, Ann N Y Acad Sci 1993 703 125 133 discussion 133-134 10.1111/j.1749-6632.1993.tb26342.x 8192290
35. Primary study authors of significant studies are more likely to believe that a strong association exists in a heterogeneous meta-analysis compared with methodologists. Panagiotou OA, Ioannidis JP, J Clin Epidemiol 2012 65 740 747 10.1016/j.jclinepi.2012.01.008 22537426
36. Content area experts as authors: helpful or harmful for systematic reviews and meta-analyses? Gøtzsche PC, Ioannidis JPA, BMJ 2012 345 7031 10.1136/bmj.e7031 23118303